The latest report by IMARC Group, titled “Blood Preparation Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the blood preparation market forecast. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global blood preparation market size reached US$ 44.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
The global market is primarily driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders necessitating regular blood transfusions. In line with this, the rising number of surgical procedures, which often require blood components, is significantly influencing the market. Furthermore, the growing awareness about blood donation and its importance in saving lives is fostering an increase in blood donations, thereby expanding the market.
Similarly, the increasing focus on personalized medicine and the need for specific blood components tailored to individual patient needs are driving innovation in blood preparation, which is creating lucrative opportunities in the market. Moreover, the expanding geriatric population, which is more prone to various ailments requiring blood transfusions, is propelling the market growth. Besides this, the rise in trauma cases and emergencies, necessitating immediate blood transfusions, is further driving the market demand.
Request to Get the Sample Report: https://www.imarcgroup.com/blood-preparation-market/requestsample
Market Trends:
The scope of the market is extensive, covering a wide array of products including whole blood, blood components, and blood derivatives used in various medical applications. The market scope is significantly growing due to continuous advancements in blood preparation and processing technologies. Moreover, the rapid integration of automated and digital solutions in blood banks and transfusion services is enhancing operational efficiency and ensuring better patient outcomes, driving market expansion.
Additionally, the increasing demand for blood components in advanced therapeutic procedures, such as stem cell therapies and regenerative medicine, is supporting growth in the market. The market scope is also benefitting from the rising trend of developing synthetic and recombinant blood products, which offer improved safety and reduced risk of infections. As per market analysis, the growing emphasis on improving blood storage and transportation systems is facilitating the availability and quality of blood products, further propelling market appeal.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/blood-preparation-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company Limited
- GlaxoSmithKline PLC
- Johnson & Johnson Services Inc.
- LEO Pharma A/S
- Pfizer Inc.
- Portola Pharmaceuticals Inc
- (Alexion Pharmaceuticals Inc.)
- Sanofi S.A
Blood Preparation Market Segmentation:
Our report has categorized the market based on region, product, antithrombotic and anticoagulants type and antithrombotic and anticoagulants application.
Breakup by Product:
- Whole Blood
- Red Cells
- Granulocytes
- Plasma
- Platelets
- Blood Components
- Whole Blood Components
- Packed Red Cells
- Leukocyte Reduced Red Blood Cells
- Frozen Plasma
- Platelet Concentrate
- Cryoprecipitate
- Blood Derivatives
Breakup by Antithrombotic and Anticoagulants Type:
- Platelet Aggregation Inhibitors
- Glycoprotein Inhibitors
- COX Inhibitors
- ADP Antagonists
- Others
- Fibrinolytics
- Tissue Plasminogen Activator (tPA)
- Streptokinase
- Urokinase
- Anticoagulants
- Heparins
- Vitamin K Antagonists
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors
Breakup by Antithrombotic and Anticoagulants Application:
- Thrombocytosis
- Pulmonary Embolism
- Renal Impairment
- Angina Blood Vessel Complications
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments